This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

Aptah Bio Inc.


Aptah Bio is a biotech startup focused on novel RNA therapies initially targeting cancer and neurodegenerative diseases. We aim to develop a new generation of RNA therapies for the treatment of sporadic genetic disorders based on a proprietary molecule class capable of modulating the spliceosome and other elements of the transcription processes in an unprecedented way, by targeting small nuclear ribonucleoproteins. It was founded in 2018 by MSc. Caio Bruno Leal (CSO) and has been led since 2020 by the CEO Rafael Bottos.